ABVC BioPharma Selects Additional Vitargus® Phase II Study Sites
Go back to ABVC BioPharma Selects Additional Vitargus® Phase II Study Sites| (NASDAQ: ABVC) | Delayed: 1.31 +0.02 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.29 | 52 Week High | $25.00 | |||
| Open | $1.32 | 52 Week Low | $1.00 | |||
| Day High | $1.33 | P/E | N/A | |||
| Day Low | $1.29 | EPS | $0.00 | |||
| Volume | 33,573 | |||||
